Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
7.85
+0.62 (8.58%)
At close: May 16, 2025, 4:00 PM
7.84
-0.01 (-0.13%)
After-hours: May 16, 2025, 7:38 PM EDT
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $604.57 million as of May 16, 2025. Its market cap has increased by 51.98% in one year.
Market Cap
604.57M
Enterprise Value
144.07M
1-Year Change
51.98%
Ranking
Category
Stock Price
$7.85
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $604.57M, an increase of 29.32%. That is a compound annual growth rate of 3.84%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 658.30B |
| Johnson & Johnson | 359.97B |
| AbbVie | 320.92B |
| Novo Nordisk | 289.00B |
| UnitedHealth Group | 248.87B |
| Abbott Laboratories | 232.01B |
| Novartis AG | 211.47B |
| AstraZeneca | 208.86B |